DE2207421C3 - 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel - Google Patents
15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende ArzneimittelInfo
- Publication number
- DE2207421C3 DE2207421C3 DE2207421A DE2207421A DE2207421C3 DE 2207421 C3 DE2207421 C3 DE 2207421C3 DE 2207421 A DE2207421 A DE 2207421A DE 2207421 A DE2207421 A DE 2207421A DE 2207421 C3 DE2207421 C3 DE 2207421C3
- Authority
- DE
- Germany
- Prior art keywords
- methylene
- acid
- methyl
- natural
- propylenedioxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (39)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE795241D BE795241A (fr) | 1972-02-11 | 15alpha, 16alpha-methylene-4-oestren-17beta-ols-methylenz-4-oestren-17beta-ols et leur procede de preparation | |
DE2207421A DE2207421C3 (de) | 1972-02-11 | 1972-02-11 | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
PL1972159970A PL81084B1 (ro) | 1972-02-11 | 1972-12-29 | |
DD168198A DD102379A5 (ro) | 1972-02-11 | 1973-01-11 | |
DK24273AA DK131037B (da) | 1972-02-11 | 1973-01-16 | Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-østren-17beta-oler. |
FI730169A FI52225C (fi) | 1972-02-11 | 1973-01-23 | Menetelmä terapeuttisesti käytettävien 15alfa,16alfa-metyleeni-4-estre eni-17beta-olien valmistamiseksi. |
ES410933A ES410933A1 (es) | 1972-02-11 | 1973-01-24 | Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles. |
YU243/73A YU35035B (en) | 1972-02-11 | 1973-01-31 | Process for preparing 15 delta, 16 delta-methylene-4-estrene-17 beta-oles |
CS73748A CS193019B2 (en) | 1972-02-11 | 1973-01-31 | Method of producing 15alpha-methylene-4-estrene-17beta-ols |
IE190/73A IE37266B1 (en) | 1972-02-11 | 1973-02-06 | 15alpha 16alpha-methylene-delta4-oestren-17beta-ols |
CA163,029A CA997753A (en) | 1972-02-11 | 1973-02-06 | PROCESS FOR PRODUCING 15.alpha., 16.alpha.-METHYLENE-.DELTA.4 OESTREN-17.beta.-OLS |
EG49/73A EG10914A (en) | 1972-02-11 | 1973-02-07 | A process for preparation 15 alpha 16 alpha methylen-4-ostren 17 b ole |
AT112473A AT327413B (de) | 1972-02-11 | 1973-02-08 | Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen |
ZA730944A ZA73944B (en) | 1972-02-11 | 1973-02-09 | 15alpha,16alpha-methylene-delta4-oestren-17beta-ols |
IL41506A IL41506A (en) | 1972-02-11 | 1973-02-09 | A 51, A61- Methylene 4 Kma-Astraen-B71- Olim |
SU1891803A SU513628A3 (ru) | 1972-02-11 | 1973-02-09 | Способ получени 15 , 16 -метилен4-эстрен-17 -олов |
GR1318A GR63160B (en) | 1972-02-11 | 1973-02-09 | 15a,16a-methyley-y-oistren-17b-olas |
CH186373A CH590883A5 (ro) | 1972-02-11 | 1973-02-09 | |
CH535776A CH593995A5 (ro) | 1972-02-11 | 1973-02-09 | |
PH14330*UA PH9370A (en) | 1972-02-11 | 1973-02-09 | 15a,16a-methylene-4-oestran-17b-ols and pharmaceutical compositions thereof |
FR7304678A FR2181719B1 (ro) | 1972-02-11 | 1973-02-09 | |
NO528/73A NO140304C (no) | 1972-02-11 | 1973-02-09 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 15alfa, 16alfa-methylen-4-oestren-17beta-oler |
KR7300246A KR780000156B1 (en) | 1972-02-11 | 1973-02-10 | Process for preparing 150 160-methylen -oestren-17-36 |
RO7373805A RO73527A (ro) | 1972-02-11 | 1973-02-10 | Procedeu de preparare a unor derivati de 15&,16&-metilen-4-oestren-17beta oli |
HUSE1666A HU165253B (ro) | 1972-02-11 | 1973-02-10 | |
AU52076/73A AU467306B2 (en) | 1972-02-11 | 1973-02-12 | 15, 16-methylene-4-oestren-17 -ols |
GB682173A GB1425636A (en) | 1972-02-11 | 1973-02-12 | 15alpha,16alpha-methylene-delta4-oestren-17beta-ols |
SE7301935A SE403781B (sv) | 1972-02-11 | 1973-02-12 | Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler |
NLAANVRAGE7301974,A NL177217C (nl) | 1972-02-11 | 1973-02-12 | Werkwijze voor de bereiding van een geneesmiddel met steroide-hormooneigenschappen, gevormd geneesmiddel en werkwijze ter bereiding van daarvoor geschikte geneeskrachtige verbindingen. |
JP48017357A JPS5829317B2 (ja) | 1972-02-11 | 1973-02-12 | 15 アルフア− 16 アルフア− − メチレン −4− エストレン −17 ベ−タ − オ−ルノセイホウ |
DK188774A DK135844C (da) | 1972-02-11 | 1974-04-04 | 15,16-methylen-4-ostren-17beta-hydroxy- eller -17beta-acyloxy-steroider til anvendelse som svangerskabsforebyggende midler |
DK188674A DK131635C (da) | 1972-02-11 | 1974-04-04 | Analogifremgangsmade til fremstilling af 15alfa, 16alfa-methylen-4-ostren-17beta-oler |
US05/484,068 US3994937A (en) | 1972-02-11 | 1974-06-28 | 15α,16α-Methylene-4-estren-17β-ols |
AT1039174A AT339514B (de) | 1972-02-11 | 1974-12-30 | Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-ostren-17beta-olen |
SE7514513A SE409329B (sv) | 1972-02-11 | 1975-12-22 | 15 alfa, 16 alfa-metylen-4-ostren-17 beta-oler till anvendning som kontraceptionsmedel |
FI770407A FI54132C (fi) | 1972-02-11 | 1977-02-08 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 15alfa 16alfa-metylen-4-estren-17beta-oler |
CS774125A CS193048B2 (en) | 1972-02-11 | 1977-06-22 | Process for preparing 15alpha,16alpha-methylen-4-estren-17beta-oles |
SE7713896A SE426834B (sv) | 1972-02-11 | 1977-12-07 | Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler |
NO782754A NO143065C (no) | 1972-02-11 | 1978-08-14 | Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2207421A DE2207421C3 (de) | 1972-02-11 | 1972-02-11 | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
DE2207421A1 DE2207421A1 (de) | 1973-08-16 |
DE2207421B2 DE2207421B2 (de) | 1980-07-24 |
DE2207421C3 true DE2207421C3 (de) | 1981-05-07 |
Family
ID=5836211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2207421A Expired DE2207421C3 (de) | 1972-02-11 | 1972-02-11 | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS5829317B2 (ro) |
KR (1) | KR780000156B1 (ro) |
AT (1) | AT327413B (ro) |
AU (1) | AU467306B2 (ro) |
BE (1) | BE795241A (ro) |
CA (1) | CA997753A (ro) |
CH (2) | CH590883A5 (ro) |
CS (1) | CS193019B2 (ro) |
DD (1) | DD102379A5 (ro) |
DE (1) | DE2207421C3 (ro) |
DK (1) | DK131037B (ro) |
EG (1) | EG10914A (ro) |
ES (1) | ES410933A1 (ro) |
FI (1) | FI52225C (ro) |
FR (1) | FR2181719B1 (ro) |
GB (1) | GB1425636A (ro) |
GR (1) | GR63160B (ro) |
HU (1) | HU165253B (ro) |
IE (1) | IE37266B1 (ro) |
IL (1) | IL41506A (ro) |
NL (1) | NL177217C (ro) |
NO (2) | NO140304C (ro) |
PH (1) | PH9370A (ro) |
PL (1) | PL81084B1 (ro) |
RO (1) | RO73527A (ro) |
SE (3) | SE403781B (ro) |
SU (1) | SU513628A3 (ro) |
YU (1) | YU35035B (ro) |
ZA (1) | ZA73944B (ro) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007027637A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
DE102007027636A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT274653B (de) * | 1966-11-10 | 1969-09-25 | Alexander Schoeller & Co Kg | Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten |
-
0
- BE BE795241D patent/BE795241A/xx not_active IP Right Cessation
-
1972
- 1972-02-11 DE DE2207421A patent/DE2207421C3/de not_active Expired
- 1972-12-29 PL PL1972159970A patent/PL81084B1/pl unknown
-
1973
- 1973-01-11 DD DD168198A patent/DD102379A5/xx unknown
- 1973-01-16 DK DK24273AA patent/DK131037B/da not_active IP Right Cessation
- 1973-01-23 FI FI730169A patent/FI52225C/fi active
- 1973-01-24 ES ES410933A patent/ES410933A1/es not_active Expired
- 1973-01-31 CS CS73748A patent/CS193019B2/cs unknown
- 1973-01-31 YU YU243/73A patent/YU35035B/xx unknown
- 1973-02-06 CA CA163,029A patent/CA997753A/en not_active Expired
- 1973-02-06 IE IE190/73A patent/IE37266B1/xx unknown
- 1973-02-07 EG EG49/73A patent/EG10914A/xx active
- 1973-02-08 AT AT112473A patent/AT327413B/de not_active IP Right Cessation
- 1973-02-09 CH CH186373A patent/CH590883A5/xx not_active IP Right Cessation
- 1973-02-09 GR GR1318A patent/GR63160B/el unknown
- 1973-02-09 CH CH535776A patent/CH593995A5/xx not_active IP Right Cessation
- 1973-02-09 PH PH14330*UA patent/PH9370A/en unknown
- 1973-02-09 ZA ZA730944A patent/ZA73944B/xx unknown
- 1973-02-09 NO NO528/73A patent/NO140304C/no unknown
- 1973-02-09 IL IL41506A patent/IL41506A/en unknown
- 1973-02-09 SU SU1891803A patent/SU513628A3/ru active
- 1973-02-09 FR FR7304678A patent/FR2181719B1/fr not_active Expired
- 1973-02-10 KR KR7300246A patent/KR780000156B1/ko active
- 1973-02-10 HU HUSE1666A patent/HU165253B/hu unknown
- 1973-02-10 RO RO7373805A patent/RO73527A/ro unknown
- 1973-02-12 JP JP48017357A patent/JPS5829317B2/ja not_active Expired
- 1973-02-12 AU AU52076/73A patent/AU467306B2/en not_active Expired
- 1973-02-12 NL NLAANVRAGE7301974,A patent/NL177217C/xx not_active IP Right Cessation
- 1973-02-12 GB GB682173A patent/GB1425636A/en not_active Expired
- 1973-02-12 SE SE7301935A patent/SE403781B/xx unknown
-
1975
- 1975-12-22 SE SE7514513A patent/SE409329B/xx not_active IP Right Cessation
-
1977
- 1977-12-07 SE SE7713896A patent/SE426834B/sv not_active IP Right Cessation
-
1978
- 1978-08-14 NO NO782754A patent/NO143065C/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH619240A5 (ro) | ||
DE3628189A1 (de) | Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene | |
DE2207421C3 (de) | 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
DE2336432A1 (de) | 3.17.18-trihydroxy-1.3.5(10)-oestratriene | |
DE2546062A1 (de) | Delta hoch 15 -steroide | |
DE1222920B (de) | Verfahren zur Herstellung von in 3-Stellung durch einen sauerstoffhaltigen Substituenten substituierten 19-Methylenderivaten der Androstanreihe | |
DE1468410A1 (de) | Verfahren zur Herstellung von 16-Methylensteroiden | |
EP0286578A1 (de) | 4,15-Disubstituierte 4-Androsten-3,17-dione und Verfahren zu deren Herstellung | |
DE2636405C2 (de) | Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate | |
EP0017094B1 (de) | 11-Methylensteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
EP0034114B1 (de) | 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate | |
DE1568175B2 (de) | 17 alpha-alka-1',3-diinylsteroide und verfahren zu ihrer herstellung | |
EP0019247A1 (de) | 16-Alpha-Alkylsteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
DE1493165C3 (de) | 1 -Hydroxyöstradiol-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel | |
DE3539244A1 (de) | 1-methyl-15(alpha)-alkyl-androsta- 1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
DE2109555B2 (de) | Neue 15 a , 16 o -Methylensteroide, diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung | |
EP0092173B1 (de) | 11Beta-Chlor-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
DE2047071C3 (de) | pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
DE1593509C3 (de) | 1-Hydroxy-7alpha-methyl-östradlol-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
DE2441647A1 (de) | 17beta-aethinyl-3,17alpha-oestradiolverbindungen, verfahren zu ihrer herstellung, arzneimittel und 17beta-aethinyl-16alpha, 17alpha-epoxyoestran-3-olverbindungen | |
DE1568175C3 (de) | 17 alpha-Alka-1 ',3-diinylsteroide und Verfahren zu ihrer Herstellung | |
DE2246462B2 (de) | ihrer Herstellung sowie diese enthaltende Arzneimittel | |
DE2158260C3 (de) | 11-Alkoxysteroide, Verfahren zu deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen | |
DE1493163C3 (de) | nalpha-Äthinyl-ie-methyl-Delta hoch 4-östren-3 beta-17 betadiole, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
DE3144049A1 (de) | 16(beta)-methyl-8(alpha)-oestradiole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OD | Request for examination | ||
C3 | Grant after two publication steps (3rd publication) |